FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
Repligen (NASDAQ: RGEN) reported Q3 EPS of $0.23, $0.07 better than the analyst estimate of $0.16. Revenue for the quarter came in at $141.2 million versus the consensus estimate of $140.67 million.
GUIDANCE:
Repligen sees FY2023 EPS of $1.70-$1.76, versus the consensus of $1.74. Repligen sees... More

